Annual Short Term Debt
$843.00 K
+$230.00 K+37.52%
December 31, 2023
Summary
- As of February 25, 2025, VRDN annual short term debt is $843.00 thousand, with the most recent change of +$230.00 thousand (+37.52%) on December 31, 2023.
- During the last 3 years, VRDN annual short term debt has risen by +$388.00 thousand (+85.27%).
- VRDN annual short term debt is now -96.83% below its all-time high of $26.61 million, reached on December 31, 2013.
Performance
VRDN Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$589.00 K
-$2.88 M-83.03%
September 30, 2024
Summary
- As of February 25, 2025, VRDN quarterly short term debt is $589.00 thousand, with the most recent change of -$2.88 million (-83.03%) on September 30, 2024.
- Over the past year, VRDN quarterly short term debt has dropped by -$232.00 thousand (-28.26%).
- VRDN quarterly short term debt is now -97.79% below its all-time high of $26.61 million, reached on December 31, 2013.
Performance
VRDN Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
VRDN Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.5% | -28.3% |
| 3 y3 years | +85.3% | -28.3% |
| 5 y5 years | -63.3% | -28.3% |
VRDN Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.1% | -83.0% | +13.3% |
| 5 y | 5-year | -78.8% | +85.3% | -88.5% | +65.9% |
| alltime | all time | -96.8% | +85.3% | -97.8% | +5456.6% |
Viridian Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $589.00 K(-83.0%) |
| Jun 2024 | - | $3.47 M(+374.2%) |
| Mar 2024 | - | $732.00 K(-13.2%) |
| Dec 2023 | $843.00 K(+37.5%) | $843.00 K(+2.7%) |
| Sep 2023 | - | $821.00 K(+2.4%) |
| Jun 2023 | - | $802.00 K(+25.9%) |
| Mar 2023 | - | $637.00 K(+3.9%) |
| Dec 2022 | $613.00 K(+17.9%) | $613.00 K(+8.7%) |
| Sep 2022 | - | $564.00 K(-2.8%) |
| Jun 2022 | - | $580.00 K(+0.2%) |
| Mar 2022 | - | $579.00 K(+11.3%) |
| Dec 2021 | $520.00 K(+14.3%) | $520.00 K(+20.9%) |
| Sep 2021 | - | $430.00 K(+4.4%) |
| Jun 2021 | - | $412.00 K(+16.1%) |
| Mar 2021 | - | $355.00 K(-22.0%) |
| Dec 2020 | $455.00 K(-88.6%) | $455.00 K(-91.1%) |
| Sep 2020 | - | $5.11 M(+34.1%) |
| Jun 2020 | - | $3.81 M(-11.0%) |
| Mar 2020 | - | $4.28 M(+7.7%) |
| Dec 2019 | $3.98 M | $3.98 M(+0.1%) |
| Sep 2019 | - | $3.97 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $3.97 M(+20.3%) |
| Mar 2019 | - | $3.30 M(+43.8%) |
| Dec 2018 | $2.29 M(+119.5%) | $2.29 M(+77.7%) |
| Sep 2018 | - | $1.29 M(+346.7%) |
| Jun 2018 | - | $289.00 K(-85.4%) |
| Sep 2017 | - | $1.98 M(+0.2%) |
| Jun 2017 | - | $1.98 M(+0.3%) |
| Mar 2017 | - | $1.97 M(+88.9%) |
| Dec 2016 | $1.04 M(-5.4%) | $1.04 M(-5.4%) |
| Sep 2016 | - | $1.10 M(0.0%) |
| Jun 2016 | - | $1.10 M(0.0%) |
| Mar 2016 | - | $1.10 M(0.0%) |
| Dec 2015 | $1.10 M(-95.8%) | $1.10 M(0.0%) |
| Sep 2015 | - | $1.10 M(0.0%) |
| Jun 2015 | - | $1.10 M(+4.4%) |
| Mar 2015 | - | $1.06 M(+9881.1%) |
| Sep 2014 | - | $10.60 K(0.0%) |
| Jun 2014 | - | $10.60 K(-98.9%) |
| Mar 2014 | - | $1.01 M(-96.2%) |
| Dec 2013 | $26.61 M(+17.8%) | $26.61 M |
| Dec 2012 | $22.59 M | - |
FAQ
- What is Viridian Therapeutics annual short term debt?
- What is the all time high annual short term debt for Viridian Therapeutics?
- What is Viridian Therapeutics annual short term debt year-on-year change?
- What is Viridian Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly short term debt year-on-year change?
What is Viridian Therapeutics annual short term debt?
The current annual short term debt of VRDN is $843.00 K
What is the all time high annual short term debt for Viridian Therapeutics?
Viridian Therapeutics all-time high annual short term debt is $26.61 M
What is Viridian Therapeutics annual short term debt year-on-year change?
Over the past year, VRDN annual short term debt has changed by +$230.00 K (+37.52%)
What is Viridian Therapeutics quarterly short term debt?
The current quarterly short term debt of VRDN is $589.00 K
What is the all time high quarterly short term debt for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly short term debt is $26.61 M
What is Viridian Therapeutics quarterly short term debt year-on-year change?
Over the past year, VRDN quarterly short term debt has changed by -$232.00 K (-28.26%)